Loading organizations...
§ Venture Capital
Special purpose vehicle investing in biotechnology companies, focused on life sciences firms developing neurodegenerative disease therapies.
Bios Memory SPV1 functions as an investment vehicle, strategically allocating capital to high-potential companies within the life sciences sector. It actively participates in syndicated financing rounds, providing crucial funding to enterprises focused on developing novel therapeutic solutions. The entity emphasizes collaborative investment, rigorously evaluating opportunities to back ventures poised for significant medical advancements.
As a special purpose vehicle, Bios Memory SPV1 lacks traditional founders or a public founding date. Its formation stems from investors pooling capital for targeted opportunities, notably its participation in a 2015 Series B financing for Cognition Therapeutics. This structure facilitates focused capital deployment into ventures addressing critical market needs.
Bios Memory SPV1 primarily supports innovative life science companies, particularly those developing therapies for complex diseases. Through its investments, the entity aims to accelerate promising treatments from research to patient care. Its long-term vision centers on contributing to breakthroughs in medical science, fostering a healthier global community.
Bios Memory SPV1 has 1 tracked investment across 1 company. The latest tracked deal is $12.0M Series B in Cognition Therapeutics in September 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 8, 2015 | Cognition Therapeutics | $12.0M Series B | Golden Seeds | ACE Fund, Ariel Southeast Angel Partners, Cowtown Angels, Dolby Family Ventures, M5invest Partners, Maine Angels, Ogden CAP, Plsg Accelerator Fund, Scale Investors, Tech Coast Angels |